metformin has been researched along with Hepato-Pulmonary Syndrome in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metformin treatment neither induced obvious hypoglycemic event nor altered hemodynamics in cirrhotic rats." | 1.46 | Metformin reduces intrahepatic fibrosis and intrapulmonary shunts in biliary cirrhotic rats. ( Chang, CC; Chuang, CL; Hsin, IF; Hsu, SJ; Huang, HC; Ko, MT; Lee, FY; Lee, SD; Lee, WS, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ko, MT | 1 |
| Huang, HC | 1 |
| Lee, WS | 1 |
| Chuang, CL | 1 |
| Hsin, IF | 1 |
| Hsu, SJ | 1 |
| Lee, FY | 1 |
| Chang, CC | 1 |
| Lee, SD | 1 |
| Liu, CW | 1 |
| Yang, YY | 1 |
2 other studies available for metformin and Hepato-Pulmonary Syndrome
| Article | Year |
|---|---|
Metformin reduces intrahepatic fibrosis and intrapulmonary shunts in biliary cirrhotic rats.
Topics: AMP-Activated Protein Kinases; Animals; Cyclooxygenase 1; Hepatopulmonary Syndrome; Liver Cirrhosis; | 2017 |
Dual organ beneficial effects of metformin in cirrhotic rats with hepatopulmonary syndrome.
Topics: Animals; Hepatopulmonary Syndrome; Liver Cirrhosis; Metformin; Rats | 2017 |